Micro Health Laboratories | Trusted Diagnostics & Healthcare Solutions

Event Details:

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions – Accreditation Section and is approved for a maximum of 3.75 hours.
DHP-AS Activity Code: A399
“The scientific planning committee has reviewed all disclosed financial relationships of speaker, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential real conflicts of interest.”
Date and Time (Qatar Time): Date: November 24, 2023, Friday (Time: 3:00 PM to 8:00 PM)
Registration Fee: 100 QR

Venue:

Majestic Ball, Icono View Restaurant Building, Holiday Villa C Ring Road, Doha

Location Map Link: Click Here

Agenda:

3:00 PM to 3:15 PM – Registration and Sign-In
3:15 PM to 3:20 PM – Welcome Message/Introducing Speaker – Mr. Shafeek Kandiyil Chalarath (Administrative Director - CPD/CME)
3:20 PM to 4:45 PM – Session 1: Mitigating Cardio-Renal risk in T2DM – Dr. Mashhood Ahmed Siddique (MBBS, ABIM, MRCP (UK) Medicine, MRCP (UK) Endocrine & Diabetes, Postgraduate Diploma in Diabetes (UK) Consultant Endocrine & Diabetes, Hamad General Hospital)
4:45 PM to 5:30 PM – Prayer Time/Coffee & Snack Break
5:30 PM to 6:55 PM – Session 2: Mitigating Cardio-Renal risk in T2DM – Dr. Mashhood Ahmed Siddique
6:55 PM to 7:45 PM – Q & A Session
7:45 PM to 7:50 PM – Program Evaluation
7:50 PM to 8:00 PM – Closing Remarks – Dr. Maha Mohammed Selim Taher (Medical Director/Chair of SPC, Laboratory Medicine/Anatomical & Clinical Pathology Consultant - Micro Health Laboratories)

Overall Learning Objectives

At the end of this activity, the participants should be able to:

Gain an understanding of the prevalence and trends of Type 2 Diabetes Mellitus (T2DM), including socio-economic and demographic determinants.
Analyze relationship between T2DM and life expectancy, exploring factors influencing longevity and the impact of T2DM management on overall health outcomes.
Identify T2DM mortality rates and the cardiovascular risk factors associated with this condition, considering prevention and intervention strategies.
This CPD activity is designed to provide valuable insights and updates on mitigating cardiovascular and renal risk in patients with Type 2 Diabetes Mellitus.

For any inquiries or assistance, please contact email: cpd@microhealthcare.com. Phone: +974 33573013

Accredited Group Learning CPD Activity (Category 1): Mitigating Cardio-Renal Risk in Diabetes Mellitus Type 2